Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III trial of bicyclol tablets for acute drug-induced liver injury
CTR20212229Phase 3Active
- Sponsor
- Beijing Union Pharmaceutical Factory
- Start
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of bicyclol in acute drug-induced liver injury (DILI), sponsored by Beijing Union Pharmaceutical Factory. Started Dec 2021; status: active.
02
Drugs
bicyclol
03
Conditions
acute drug-induced liver injury (DILI)
Beyond the preview
Go deeper on CTR20212229.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20212229.